Correlation Between Vertex Pharmaceuticals and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals Incorporated and BB Biotech AG, you can compare the effects of market volatilities on Vertex Pharmaceuticals and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and BB Biotech.

Diversification Opportunities for Vertex Pharmaceuticals and BB Biotech

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vertex and BBZA is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals Incorpo and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals Incorporated are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and BB Biotech go up and down completely randomly.

Pair Corralation between Vertex Pharmaceuticals and BB Biotech

Assuming the 90 days horizon Vertex Pharmaceuticals Incorporated is expected to generate 1.19 times more return on investment than BB Biotech. However, Vertex Pharmaceuticals is 1.19 times more volatile than BB Biotech AG. It trades about 0.07 of its potential returns per unit of risk. BB Biotech AG is currently generating about -0.03 per unit of risk. If you would invest  37,170  in Vertex Pharmaceuticals Incorporated on September 3, 2024 and sell it today you would earn a total of  6,935  from holding Vertex Pharmaceuticals Incorporated or generate 18.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceuticals Incorpo  vs.  BB Biotech AG

 Performance 
       Timeline  
Vertex Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Vertex Pharmaceuticals and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vertex Pharmaceuticals and BB Biotech

The main advantage of trading using opposite Vertex Pharmaceuticals and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind Vertex Pharmaceuticals Incorporated and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity